Viewing Study NCT02533258


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-03-06 @ 6:11 PM
Study NCT ID: NCT02533258
Status: COMPLETED
Last Update Posted: 2025-07-16
First Post: 2015-08-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha View